Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa”), a clinical-stage specialty biopharmaceutical company developing ...

As of March 31, 2025, Tonix had $131.7 million of cash and cash equivalents, compared to $98.8 million as of December 31, 2024. Net cash used in operations was approximately $16.6 million for first ...

Prosecutors in opening statements called Combs a cultural icon to the public – but alleged he 'committed crime after crime' ...